Latest Regulatory News

Nexalis Therapeutics has initiated dosing in its Phase 1 trial of IRX-616a, a novel cannabidiol inhalation treatment targeting panic disorder. The trial aims to evaluate safety and pharmacokinetics, with dose escalation decisions expected soon.

Resouro Strategic Metals has appointed Simon Stilwell as Independent Non-Executive Chairman, with Christopher Eager stepping into the CEO role, marking a significant leadership reshuffle as the company advances its rare earths and titanium projects in Brazil.

Caspin Resources has successfully completed a $6 million placement and exercised options, bolstering its position in promising Australian mineral projects focused on tin and gold.

Imricor Medical Systems has filed a Form 10 registration with the U.S. SEC, marking its transition to a U.S. reporting company amid ongoing FDA clearances and clinical trials. This move signals a significant step in its early commercialisation of MRI-guided cardiac ablation technology.

Horizon Oil has released a first supplementary and replacement bidder’s statement for its off-market takeover offer for Cue Energy, proposing a mix of cash and shares that values Cue at a 10-14% premium. The deal aims to create a diversified oil and gas producer across Asia-Pacific with significant synergies.

Lakes Blue Energy has temporarily halted gas flow testing at its Wombat-5 well to conduct extended pressure analysis, planning a perforation program to enhance production prospects.

Chimeric Therapeutics Limited has announced a significant 100-to-1 security consolidation affecting shares, options, and performance rights, pending shareholder approval and set for implementation in April 2026.

EBR Systems marked a pivotal transition in 2025 with FDA approval of its WiSE CRT System and the initiation of U.S. commercial implants, generating $1.6 million in revenue. Despite this progress, the company reported a net loss of $48.8 million and completed a significant capital raise to support ongoing growth.

Neometals Ltd has released a positive scoping study for its Ironclad gold deposit at the Barrambie Gold Project, outlining a rapid production pathway with potential output of up to 11,000 ounces of gold within a year.

Infotrust has agreed to acquire Canberra-based Catalyst Cyber, marking a strategic push into federal government cyber security markets with an expected earnings boost from the deal.

GR Engineering Services Limited has updated its dividend announcement, confirming a fully franked ordinary dividend of AUD 0.12 per share and setting the Dividend Reinvestment Plan price at AUD 3.9507 with a 2.5% discount.

EVE Health Group has increased its placement funding to $1.3 million, backed by a cornerstone investor with pharmaceutical expertise, advancing its reformulated drug programs targeting billion-dollar global markets.